Differences in characteristics and outcomes of older patients hospitalized for COVID-19 after introduction of vaccination
- PMID: 38861241
- PMCID: PMC11377515
- DOI: 10.1007/s41999-024-01002-0
Differences in characteristics and outcomes of older patients hospitalized for COVID-19 after introduction of vaccination
Abstract
Purpose: The aim of the present study was to investigate characteristics and outcomes in vaccinated and unvaccinated older patients hospitalized for COVID-19 infection.
Methods: A retrospective multicentre cohort study among patients aged ≥70 years hospitalized for COVID-19 infection.
Results: 263 vaccinated and 82 unvaccinated patients were included. Vaccinated patients were older (median age 79 vs. 76 years; p < 0.001), more patients were male (66.2% vs. 53.7%; p = 0.040), had more comorbidities [median Charlson Comorbidity Index (CCI) 2 vs. 1; p 0.016] and were frailer [Clinical Frailty Scale (CFS) ≥ 4 68% vs. 49%; p 0.015]. Vaccinated patients were admitted earlier after symptom onset (median 5 days vs. 7 days) but were equally ill at time of hospital admission. After correction for frailty, comorbidity and disease severity, risk of in-hospital mortality was three times lower for vaccinated patients (HR 0.30 95% CI 0.16-0.56; p < 0.001) compared to unvaccinated patients.
Conclusion: Vaccinated patients had lower risk of in-hospital mortality than unvaccinated patients with COVID-19 infection. These findings suggest that vaccinated patients benefit from the protective effect of the vaccine against death during hospital stay, outweighing the increased mortality risk that is associated with older age, greater frailty and more numerous comorbidities. This could be an encouragement for older people to receive age-appropriate vaccines, although no definite conclusions can be drawn for this was no intervention study.
Keywords: COVID-19; Frailty; In-hospital mortality; Older patient; Vaccination.
© 2024. The Author(s).
Conflict of interest statement
The authors have no competing interests.
Similar articles
-
Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.JAMA Netw Open. 2022 Oct 3;5(10):e2238871. doi: 10.1001/jamanetworkopen.2022.38871. JAMA Netw Open. 2022. PMID: 36301541 Free PMC article.
-
Impact of vaccination against SARS-CoV-2 on mortality risk, ICU admission rate, and hospitalization length in hospitalized COVID-19 patients: a cross-sectional study.BMC Infect Dis. 2025 Jan 31;25(1):144. doi: 10.1186/s12879-025-10530-4. BMC Infect Dis. 2025. PMID: 39885405 Free PMC article.
-
Frailty is associated with in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands: the COVID-OLD study.Age Ageing. 2021 May 5;50(3):631-640. doi: 10.1093/ageing/afab018. Age Ageing. 2021. PMID: 33951156 Free PMC article.
-
Comparing associations between frailty and mortality in hospitalised older adults with or without COVID-19 infection: a retrospective observational study using electronic health records.Age Ageing. 2021 Feb 26;50(2):307-316. doi: 10.1093/ageing/afaa167. Age Ageing. 2021. PMID: 32678866 Free PMC article.
-
What is the relationship between validated frailty scores and mortality for adults with COVID-19 in acute hospital care? A systematic review.Age Ageing. 2021 May 5;50(3):608-616. doi: 10.1093/ageing/afab008. Age Ageing. 2021. PMID: 33951151 Free PMC article.
Cited by
-
The prognostic value of Clinical Frailty Scale in COVID-19 pneumonia across different pandemic phases: a comparison between the first and the fourth wave.Front Med (Lausanne). 2025 Mar 27;12:1549444. doi: 10.3389/fmed.2025.1549444. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40212274 Free PMC article.
-
Validation of the acutely presenting older patient screener for short term mortality prediction in older patients hospitalized for COVID-19.Eur Geriatr Med. 2025 Aug;16(4):1519-1526. doi: 10.1007/s41999-025-01200-4. Epub 2025 Apr 22. Eur Geriatr Med. 2025. PMID: 40261576 Free PMC article.
References
-
- Haas EJ et al (2021) Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 397(10287):1819–1829 10.1016/S0140-6736(21)00947-8 - DOI - PMC - PubMed
-
- RIVM (2024) Figues on the COVID-19 vaccination programme. https://www.rivm.nl/en/coronavirus-covid-19/current/vaccination-figures. Accessed 17 Jan 2024
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical